Resultados de la búsqueda 441-450 of 17383 for B cell lymphomas
... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. ... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. ... lymphoma (B ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Study of CA-4948 in Patients With ... A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell ...
... b-cell lymphoma (DLBCL) patients with out of specification ... cells by blocking some of the enzymes needed for cell growth. A Clinical Use ...
... Cell Leukemia (MCL). Ascorbic Acid and ... Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma.
... Cell Lung Cancer. A Study of 177Lu-FAP-2286 in Advanced Solid Tumors ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... Cell Leukemia (MCL). A Study of ... Axicabtagene Ciloleucel Versus Standard Of Care Therapy As First-Line Therapy In High-Risk Large B-Cell Lymphoma.
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?